Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Expert Review of Anticancer Therapy
|
May 27, 2024
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma
Paola Tacchetti, Marco Talarico, Simona Barbato, et al.
Cancers
|
April 14, 2025
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
Cancers
|
August 14, 2025
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. <i>Cancers</i> 2025, <i>17</i>, 1168
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
American Journal of Hematology
|
October 5, 2022
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
Paola Tacchetti, Serena Rocchi, Elena Zamagni, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2024
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review
Flavia Bigi, Enrica Manzato, Simona Barbato, et al.
The New Microbiologica
|
October 21, 2015
First Italian Ebola virus disease case: management of hospital internal and external communication
Lorella Salce, Simona Barbato, Daniela Renna, et al.
Clinical and Experimental Medicine
|
May 27, 2025
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home
Flavia Bigi, Mauro Fiacchini, Roberta Restuccia, et al.
Leukemia & Lymphoma
|
March 18, 2021
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study
Ilaria Rizzello, Michele Cavo, Luca Dozza, et al.
Frontiers in Oncology
|
October 23, 2025
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma
Marco Talarico, Gisella Vischini, Simona Barbato, et al.
Frontiers in Oncology
|
June 12, 2023
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
Katia Mancuso, Elena Zamagni, Vincenza Solli, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Expert Review of Anticancer Therapy
|
May 27, 2024
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma
Paola Tacchetti, Marco Talarico, Simona Barbato, et al.
Cancers
|
April 14, 2025
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
Cancers
|
August 14, 2025
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. <i>Cancers</i> 2025, <i>17</i>, 1168
Katia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.
American Journal of Hematology
|
October 5, 2022
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
Paola Tacchetti, Serena Rocchi, Elena Zamagni, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2024
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review
Flavia Bigi, Enrica Manzato, Simona Barbato, et al.
The New Microbiologica
|
October 21, 2015
First Italian Ebola virus disease case: management of hospital internal and external communication
Lorella Salce, Simona Barbato, Daniela Renna, et al.
Clinical and Experimental Medicine
|
May 27, 2025
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home
Flavia Bigi, Mauro Fiacchini, Roberta Restuccia, et al.
Leukemia & Lymphoma
|
March 18, 2021
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study
Ilaria Rizzello, Michele Cavo, Luca Dozza, et al.
Frontiers in Oncology
|
October 23, 2025
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma
Marco Talarico, Gisella Vischini, Simona Barbato, et al.
Frontiers in Oncology
|
June 12, 2023
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
Katia Mancuso, Elena Zamagni, Vincenza Solli, et al.
Page
of 3